More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/Mouse anti Human Matrix Metalloproteinase 2 (MMP2)

Mouse anti Human Matrix Metalloproteinase 2 (MMP2)

Research Use Only
X2054M
Nordic-MUbio
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetMMP2
Price on request
200 ug
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    Nordic-MUbio
  • Product Name
    Mouse anti Human Matrix Metalloproteinase 2 (MMP2)
  • Delivery Days Customer
    7
  • Application Supplier Note
    Antibody can be used for Western blotting (1-2 microg/ml) and immunohistochemistry on formlin-fixed paraffin-embedded tissue sections (1-5 microg/ml). Optimal concentration should be evaluated by serial dilutions.
  • Applications
    Western Blot, ELISA, ImmunoHistoChemistry
  • Applications Supplier
    Western Blotting;ELISA;Western Blotting;Immunohistochemistry
  • Category Supplier
    Primary antibodies
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    4D3
  • Conjugate
    Unconjugated
  • Gene ID4313
  • Target name
    MMP2
  • Target description
    matrix metallopeptidase 2
  • Target synonyms
    72 kDa type IV collagenase; CLG4; CLG4A; collagenase type IV-A; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase); matrix metalloproteinase-2; matrix metalloproteinase-II; MMP-2; MMP-II; MONA; neutrophil gelatinase; TBE-1
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDP08253
  • Protein Name
    72 kDa type IV collagenase
  • Scientific Description
    MMP2; MMP-2; CLG4; CLG4A; Matrix metallopeptidase 2; 72 kDa Type IV collagenase precursor; 72 kDa gelatinase, Gelatinase A
  • Shelf life instruction
    See expiration date on vial
  • Reactivity
    Human
  • Reactivity Supplier
    Human
  • Reactivity Supplier Note
    Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized with a synthetic peptide derived from the C-terminus of the human MMP2 protein and mouse myeloma Ag8563 cells.
  • UNSPSC
    12352203

References

  • 1. Talvensaari-Mattila, A., et al. (2005). Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma. Anticancer Res. 25(6B);4101-4105. 2. Honkavuori, M., et al. (2007). MMP-2 expression associates with CA125 and clinical course in endometrial carcinoma. Gynecol. Oncol. 104(1);217-221.